Prothrombotic Rebound After Discontinuation of Direct Oral Anticoagulants Therapy: A Systematic Review
Open Access
- 3 November 2024
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (21) , 6606
Abstract
Background/Objectives: The practice of holding anticoagulation is a relatively common approach, with the aim of either preventing excessive bleeding in preparation for surgical procedures or managing acute bleeding episodes. Methods: To assess the relationship between the discontinuation of direct oral anticoagulants (DOACs) therapy and the condition of hypercoagulability, a systematic review of the literature was conducted, following PRISMA guidelines, in PubMed/MEDLINE, Cochrane, and Google Scholar. These databases were searched for all publications that described a rebound phenomenon or hypercoagulability state after DOACs discontinuation. Results: A total of 1494 articles were selected from searched databases, and 29 were eligible. A final total of 16 case reports and 14 original research articles were subjected to analysis. Conclusions: The results of this study indicate that the cessation of DOAC therapy may be associated with an increased risk of thrombotic events. More studies are required to ascertain whether DOACs treatment cessation can be linked to rebound phenomena associated with thromboembolic events. This will provide the data needed to determine the incidence and risk of this phenomenon.Keywords
Funding Information
- Wroclaw Medical University (SUBZ.B180.24.058)
- Wrocław University of Environmental and Life Sciences (SUBZ.B180.24.058)
This publication has 66 references indexed in Scilit:
- Hemostatic balance between pro‐ and anticoagulant is maintained during glucocorticoid treatmentPediatric Blood & Cancer, 2023
- Risk of ischemic stroke associated with direct oral anticoagulants discontinuation on patients with non‐valvular atrial fibrillationPharmacoepidemiology and Drug Safety, 2023
- Short‐Term Cessation of Dabigatran Causes a Paradoxical Prothrombotic StateAnnals of Neurology, 2020
- Differences in prothrombotic response between the uninterrupted and interrupted apixaban therapies in patients undergoing cryoballoon ablation for paroxysmal atrial fibrillation: a randomized controlled studyHeart and Vessels, 2019
- Dual Antithrombotic Therapy with Clopidogrel and Novel Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Real-world StudyCardiology and Therapy, 2018
- Left atrial thrombus formation after brief interruption of rivaroxabanThe American Journal of Emergency Medicine, 2016
- A Head-to-Head Comparison of Periprocedural Coagulability Under Anticoagulation with Rivaroxaban Versus Dabigatran in Patients Undergoing Ablation of Atrial FibrillationClinical Drug Investigation, 2013
- Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction?Journal of Thrombosis and Thrombolysis, 2012
- Effect of acute exercise on the raised plasma fibrinogen, soluble P‐Selectin and von willebrand factor levels in chronic atrial fibrillationClinical Cardiology, 2001
- Laboratory measurement of thrombin activity?What every clinician scientist needs to knowJournal of Thrombosis and Thrombolysis, 1995